Dianthus Therapeutics
Stock Forecast, Prediction & Price Target
Dianthus Therapeutics (DNTH) stock Price Target by analysts
$52
Potential upside: 128.67%
Dianthus Therapeutics price prediction
What is Dianthus Therapeutics stock analysts` prediction?
Dianthus Therapeutics stock forecast: Based on 1 Wall Street analysts` predicted price targets for Dianthus Therapeutics in the last 3 months, the avarage price target is $52, with a high forecast of $NaN. The average price target represents a 128.67% change from the last price of $22.74.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Dianthus Therapeutics stock Price Target by analysts
Full breakdown of analysts given Dianthus Therapeutics price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Leland Gershell Oppenheimer | 0% 0/1 | 11 months ago | $52 128.67% upside | $28.73 | StreetInsider | Previous targets (0) |
Steven Seedhouse Raymond James | 0% 0/1 | over 1 year ago | $51 124.27% upside | $24.15 | TheFly | Previous targets (0) |
Dianthus Therapeutics Financial Estimates
Dianthus Therapeutics Revenue Estimates
Dianthus Therapeutics EBITDA Estimates
Dianthus Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $1.47M N/A | $6.41M 334.75% | $2.82M -55.96% | Avg: $1.75M Low: $1.22M High: $2.69M avg. -38.01% | Avg: $2.70M Low: $1.44M High: $4.58M avg. 54.54% | Avg: $17.16M Low: $9.17M High: $29.06M avg. 534.14% | Avg: $76.61M Low: $40.94M High: $129.70M avg. 346.25% |
Net Income
% change YoY
| $-13.10M N/A | $-28.47M -117.22% | $-43.55M -52.95% | Avg: $-89.05M Low: $-17.41M High: $-10.20M avg. -104.46% | Avg: $-120.80M Low: $-27.57M High: $-10.87M avg. -35.65% | Avg: $-18.60M Low: $-35.36M High: $-7.34M avg. 84.60% | Avg: $-17.88M Low: $-33.99M High: $-7.05M avg. 3.87% |
EBITDA
% change YoY
| $-13.06M N/A | $-29.69M -127.36% | $-48.17M -62.23% | Avg: $-350.34K Low: $-538.27K High: $-245.64K avg. 99.27% | Avg: $-541.43K Low: $-916.70K High: $-289.35K avg. -54.54% | Avg: $-3.43M Low: $-5.81M High: $-1.83M avg. -534.14% | Avg: $-15.32M Low: $-25.94M High: $-8.18M avg. -346.25% |
EPS
% change YoY
| -$3.82 N/A | -$32.57 -752.61% | -$8.45 74.05% | Avg: -$2.64 Low: -$3.38 High: -$1.98 avg. 68.80% | Avg: -$3.25 Low: -$5.35 High: -$2.11 avg. -23.38% | Avg: -$3.61 Low: -$6.86 High: -$1.43 avg. -11.00% | Avg: -$3.47 Low: -$6.6 High: -$1.37 avg. 3.87% |
Operating Expenses
% change YoY
| $14.56M N/A | $36.12M 148.05% | $51M 41.18% | Avg: $3.74M Low: $2.62M High: $5.74M avg. -92.66% | Avg: $5.78M Low: $3.08M High: $9.78M avg. 54.54% | Avg: $36.65M Low: $19.59M High: $62.06M avg. 534.14% | Avg: $163.57M Low: $87.42M High: $276.95M avg. 346.25% |
FAQ
What is Dianthus Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -12.91% in 2025-2028.
We have gathered data from 7 analysts. Their low estimate is -17.41M, average is -89.05M and high is -10.20M.
What is Dianthus Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 224.23% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is $1.22M, average is $1.75M and high is $2.69M.
What is Dianthus Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 9.57% in 2025-2028.
We have gathered data from 7 analysts. Their low earnings per share estimate is -$3.38, average is -$2.64 and high is $-1.98.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Dianthus Therapeutics stock. The most successful analyst is Leland Gershell.